Sign in Register

Mustargen (mechlorethamine HCl)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

Generic name: mechlorethamine HCl

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Mustargen

Intelligence content is not available yet.

Indications

The following indications are listed for Mustargen:

  • Chronic Lymphoid Leukemia
  • Chronic Myelocytic Leukemia
  • Cutaneous T-Cell Lymphoma
  • Hodgkin's Lymphoma
  • Malignant Ascites
  • Malignant Neoplasm Of Lung
  • Mycosis Fungoides
  • Non-Hodgkin's Lymphoma
  • Pericardial Malignant Effusion
  • Pleural Malignant Effusion
  • Polycythemia Vera

Also known as: Anemia Lymphatica, Chronic Granulocytic Leukemia, Chronic Leukemic Myelosis, Chronic Myelogenic Leukemia, Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia, Hodgkin's Disease, Malignant Pericardial Effusions, Malignant Peritoneal Effusion, Malignant Pleural Effusion, Malignant Tumor Of Lung, Non-Hodgkin's Type Lymphoma, Peritoneal Malignant Effusion, Primary Cutaneous T-Cell Lymphoma, Small Cerebriform Cell Lymphoma.

Dosing

No dosing information is available for this tab.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

No ICD codes are available for this drug.

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a 5-digit ZIP code. Searching does not change your profile.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data